z-logo
open-access-imgOpen Access
The increased risk of cardiovascular events in chronic kidney disease: pathogenetic mechanisms, the possibility of correction
Author(s) -
O. Yu. Barysheva,
A. A Melentieva,
L. M Kheyfetz,
A. T. Balashov
Publication year - 2014
Publication title -
cardiosomatics
Language(s) - English
Resource type - Journals
eISSN - 2658-5707
pISSN - 2221-7185
DOI - 10.26442/cs45133
Subject(s) - hyperphosphatemia , kidney disease , medicine , dyslipidemia , fibroblast growth factor 23 , pathogenesis , klotho , secondary hyperparathyroidism , calciphylaxis , disease , risk factor , intensive care medicine , bioinformatics , kidney , parathyroid hormone , biology , calcium
The paper discusses the pathogenetic mechanisms linking cardiovascular risk and chronic kidney disease (CKD). Presents data on the role of hypercalcemia, hyperphosphatemia, secondary hyperparathyroidism, fibroblast growth factor-23, Klotho, an important the components of the pathogenesis of mineral and bone disorders increase the risk cardiovascular events in CKD. Discussed the causes and features dyslipidemia in CKD, particularly correction. Presents data on options calciphylaxis, causes, development, peculiarities of treatment.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom